Bond.az reports that JP Morgan downgraded Endava to Underweight from Neutral, citing persistent execution issues and weak client demand.
The brokerage cut its price target to $5 from $9. Endava missed Q3 revenue estimates and lowered its full-year outlook.
AI-related revenue accounted for 15% of sales, but large AI deals are taking longer to close, limiting near-term upside.











